Ontology highlight
ABSTRACT: Background and purpose
The in vivo oestrogenicity of genistein and its glycoside genistin is still under debate. The present study aimed to develop a physiologically based kinetic (PBK) model that provides insight in dose-dependent plasma concentrations of genistein aglycone and its metabolites and enables prediction of in vivo oestrogenic effective dose levels of genistein and genistin in humans.Experimental approach
A PBK model for genistein and genistin in humans was developed based on in vitro metabolic parameters. The model obtained was used to translate in vitro oestrogenic concentration-response curves of genistein to in vivo oestrogenic dose-response curves for intake of genistein and genistin.Key results
The model predicted that genistein-7-O-glucuronide wa
SUBMITTER: Boonpawa R
PROVIDER: S-EPMC5523000 | biostudies-literature | 2017 Aug
REPOSITORIES: biostudies-literature